Fintel reports that on January 14, 2025, Craig-Hallum initiated coverage of LifeVantage (NasdaqCM:LFVN) with a Buy ...

LifeVantage (NASDAQ:LFVN – Get Free Report) and Checkpoint Therapeutics (NASDAQ:CKPT – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the ...

Technology leader brings decades of expertise in innovation, scalability and customer-focused solutions to accelerate ...

Corporation announces the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of ...

"Second quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System we launched in October in the United States along with outstanding execution by our team to ...

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

The firm increased its portfolio allocation in LFVN by 61.56% over the last quarter. Capital Management holds 420K shares representing 3.35% ownership of the company. VTSMX - Vanguard Total Stock ...

Lake Street analyst Brooks O’Neil maintained a Buy rating on LifeVantage (LFVN – Research Report) today and set a price target of $26.00. The ...

LifeVantage's (NASDAQ:LFVN) stock is up by a considerable 55% over the past three months. Given that stock prices ...

LifeVantage Corporation® (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular ...